USPTO serial 88266197
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Chad E. King
Chad E. King ADSERO IP8210 SOUTHPARK TERRACELITTLETON, CO 80120UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for measurement and analysis of human body's autonomic nervous system, physical parameters and other physiological data, bio-signals, and bodily behavior, and for displaying, storing, sending, transmitting and receiving of instructions and data relating to all of the above; downloadable computer databases featuring data from measurement and analysis of human body's autonomic nervous system, physical parameters and other physiological data, bio-signals, and bodily behavior, and for displaying, storing, sending, transmitting and receiving of instructions and data relating to any of the above; wearable computer devices for transmitting data to smartphones or other computers or handheld devices | ACTIVE | — |
| 010 | Devices and instruments for measuring and analyzing human body's autonomic nervous system, physical parameters and other physiological data, bio-signals, and bodily behavior, and for displaying, storing, sending, transmitting and receiving instructions and data relating to any of the above, for medical and therapeutic purposes | ACTIVE | — |
| 042 | Medical and scientific research and development in the field of neuroscience, namely, autonomic nervous system disorders; software as a service (SaaS) featuring software for use in management of databases featuring data from measurement and analysis of human body's autonomic nervous system, physical parameters and other physiological data, bio-signals, and bodily behavior; platform as a service (PAAS) featuring computer software platforms for data collection and data analytics for use in the field of neurological disorders and disorders of the autonomic nervous system | ACTIVE | — |
| 044 | Medical consultation and evaluation services for measurement and analysis of human body's autonomic nervous system, physical parameters and other physiological data, bio-signals for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of neurological disorders and disorders of the autonomic nervous system; medical diagnostic testing, monitoring and reporting services; Medical consultation and evaluation services for measurement and analysis of human body's autonomic nervous system, physical parameters and other physiological data, and bio-signals for diagnostic or treatment purposes | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 22, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 22, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 24, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 22, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 22, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 22, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 16, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 14, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 14, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 14, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 16, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 21, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 21, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 1, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 15, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 14, 2019 | ALIE | ASSIGNED TO LIE | — |
| Mar 29, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 29, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 29, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 29, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 29, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 29, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 9, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 21, 2019 | NWAP | NEW APPLICATION ENTERED | — |